MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Grows Stock Holdings in Lam Research Corporation $LRCX

Key Points

• MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its stake in Lam Research Corporation by 8.5%, owning now 220,493 shares valued at approximately $21.46 million.
• Several brokerages have upgraded their target prices for Lam Research, with Goldman Sachs starting coverage with a "buy" rating and a $115 target, while Argus raised its target from $105 to $120.
• Lam Research announced a quarterly dividend increase to $0.26 per share, reflecting a 13% increase from the previous dividend, with a scheduled payment on October 15th.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH raised its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 8.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 220,493 shares of the semiconductor company's stock after purchasing an additional 17,234 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in Lam Research were worth $21,463,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Empowered Funds LLC raised its position in Lam Research by 10.5% during the first quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company's stock valued at $13,629,000 after purchasing an additional 17,833 shares in the last quarter. Pinnacle Financial Partners Inc bought a new position in shares of Lam Research during the first quarter valued at about $201,000. Cookson Peirce & Co. Inc. bought a new position in shares of Lam Research during the first quarter valued at about $607,000. China Universal Asset Management Co. Ltd. grew its stake in shares of Lam Research by 27.1% during the first quarter. China Universal Asset Management Co. Ltd. now owns 49,505 shares of the semiconductor company's stock valued at $3,607,000 after buying an additional 10,565 shares during the last quarter. Finally, First Citizens Bank & Trust Co. grew its stake in shares of Lam Research by 47.8% during the first quarter. First Citizens Bank & Trust Co. now owns 121,902 shares of the semiconductor company's stock valued at $8,862,000 after buying an additional 39,414 shares during the last quarter. Hedge funds and other institutional investors own 84.61% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on LRCX. The Goldman Sachs Group began coverage on shares of Lam Research in a report on Thursday, July 10th. They issued a "buy" rating and a $115.00 target price on the stock. Argus raised their target price on Lam Research from $105.00 to $120.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Stifel Nicolaus raised their target price on Lam Research from $92.00 to $110.00 and gave the stock a "buy" rating in a research note on Tuesday, July 29th. KeyCorp lifted their price objective on Lam Research from $105.00 to $115.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Finally, Needham & Company LLC lifted their price objective on Lam Research from $110.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $111.35.

Lam Research Stock Performance

Shares of LRCX opened at $128.32 on Thursday. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. The business's 50 day moving average price is $105.18 and its 200-day moving average price is $89.35. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $133.57. The stock has a market cap of $161.82 billion, a P/E ratio of 30.85, a P/E/G ratio of 1.68 and a beta of 1.76.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. During the same period in the previous year, the firm posted $1.03 EPS. The business's revenue for the quarter was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, September 24th. This is an increase from Lam Research's previous quarterly dividend of $0.23. Lam Research's dividend payout ratio (DPR) is presently 22.12%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.